These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6173696)

  • 1. Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon.
    Herberman RB; Ortaldo JR; Timonen T
    Methods Enzymol; 1981; 79(Pt B):477-84. PubMed ID: 6173696
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RR; Ortaldo JR; Bonnard GD
    Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
    [No Abstract]   [Full Text] [Related]  

  • 3. Locus of selective depression of human natural killer cells by azathioprine.
    Shih WW; Ellison GW; Myers LW; Durkos-Smith D; Fahey JL
    Clin Immunol Immunopathol; 1982 Jun; 23(3):672-81. PubMed ID: 6180857
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of human natural cell-mediated cytotoxicity by interferon.
    Moore M; Potter MR
    Br J Cancer; 1980 Mar; 41(3):378-87. PubMed ID: 6155926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of human antibody-dependent cellular cytotoxicity and mononuclear phagocytosis by procaine.
    Olinescu A; Hristescu S; Dincă-Avarvarei L; Marx A; Petrovici A; Gagheş A; Toporan M; Vasiliu E
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):63-72. PubMed ID: 3862368
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of antibody-dependent cellular cytotoxicity and natural cytotoxicity by retinoic acid.
    Eremin O; Ashby J; Rhodes J
    Int Arch Allergy Appl Immunol; 1984; 75(1):2-7. PubMed ID: 6204945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.
    Fitzharris P; Alcocer J; Stephens HA; Knight RA; Snaith ML
    Clin Exp Immunol; 1982 Jan; 47(1):110-8. PubMed ID: 6178542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of human ADCC with interferon.
    Warren R; Kalamasz D; Storb R
    Clin Exp Immunol; 1982 Oct; 50(1):183-8. PubMed ID: 6184191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 augments natural killer cell activity.
    Henney CS; Kuribayashi K; Kern DE; Gillis S
    Nature; 1981 May; 291(5813):335-8. PubMed ID: 6164929
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological studies in chronic lymphocytic leukemia.-II. Natural killer- and antibody-dependent cellular cytotoxicity potentials of malignant and non-malignant lymphocyte subsets and the effect of alpha-interferon.
    Hokland P; Ellegaard J
    Leuk Res; 1981; 5(4-5):349-55. PubMed ID: 6169962
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity of human natural killer cells to hyperthermia.
    Azocar J; Yunis EJ; Essex M
    Lancet; 1982 Jan; 1(8262):16-7. PubMed ID: 6172681
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product.
    Ausiello C; Hokland P; Heron I
    Scand J Immunol; 1981; 13(3):263-70. PubMed ID: 6165076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpromazine inhibits human natural killer cell activity and antibody-dependent cell-mediated cytotoxicity.
    Steele TA; Brahmi Z
    Biochem Biophys Res Commun; 1988 Sep; 155(2):597-602. PubMed ID: 3262340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell function in trisomy-21 (Down's syndrome).
    Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
    Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon: a perspective.
    Weissman RM; Droller MJ
    Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
    Lotzová E; Savary CA; Gutterman JU; Hersh EM
    Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of levamisole on human natural killer and killer cell activity and production of interferons.
    Liberati M; Borden EC; McBain JA; Raubertas R
    Immunopharmacology; 1982 Oct; 5(1):11-8. PubMed ID: 6182126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.
    Herberman RB; Ortaldo JR; Rubinstein M; Pestka S
    J Clin Immunol; 1981 Jul; 1(3):149-53. PubMed ID: 6174540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.